203 related articles for article (PubMed ID: 32253527)
1. Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation.
Altaani BM; Almaaytah AM; Dadou S; Alkhamis K; Daradka MH; Hananeh W
Pharm Res; 2020 Apr; 37(4):80. PubMed ID: 32253527
[TBL] [Abstract][Full Text] [Related]
2. Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo.
Guo L; Ma E; Zhao H; Long Y; Zheng C; Duan M
Int J Pharm; 2011 Nov; 420(1):172-9. PubMed ID: 21888960
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Characterization of an Oral Norethindrone Sustained Release/Controlled Release Nanoparticles Formulation Based on Chitosan.
Altaani BM; Al-Nimry SS; Haddad RH; Abu-Dahab R
AAPS PharmSciTech; 2019 Jan; 20(2):54. PubMed ID: 30617756
[TBL] [Abstract][Full Text] [Related]
4. Low Molecular Weight Chitosan-Insulin Complexes Solubilized in a Mixture of Self-Assembled Labrosol and Plurol Oleaque and Their Glucose Reduction Activity in Rats.
Elsayed AM; Khaled AH; Al Remawi MM; Qinna NA; Abu Farsakh H; Badwan AA
Mar Drugs; 2018 Jan; 16(1):. PubMed ID: 29337857
[TBL] [Abstract][Full Text] [Related]
5. Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release.
Della Porta G; Campardelli R; Cricchio V; Oliva F; Maffulli N; Reverchon E
J Pharm Sci; 2016 Jul; 105(7):2164-72. PubMed ID: 27290629
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide.
Bahari Javan N; Montazeri H; Rezaie Shirmard L; Jafary Omid N; Barbari GR; Amini M; Ghahremani MH; Rafiee-Tehrani M; Abedin Dorkoosh F
Eur J Pharm Sci; 2017 Apr; 101():167-181. PubMed ID: 28193537
[TBL] [Abstract][Full Text] [Related]
7. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
8. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
9. PTH 1-34 loaded thiolated chitosan nanoparticles for osteoporosis: oral bioavailability and anabolic effect on primary osteoblast cells.
Narayanan D; Anitha A; Jayakumar R; Chennazhi KP
J Biomed Nanotechnol; 2014 Jan; 10(1):166-78. PubMed ID: 24724508
[TBL] [Abstract][Full Text] [Related]
10. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled insulin and nanogels polyelectrolyte complex (Ins/NGs-PEC) for oral insulin delivery: characterization, lyophilization and in-vivo evaluation.
Mudassir J; Darwis Y; Muhamad S; Khan AA
Int J Nanomedicine; 2019; 14():4895-4909. PubMed ID: 31456636
[No Abstract] [Full Text] [Related]
12. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex.
Hwang SR; Seo DH; Byun Y; Park JW
Int J Nanomedicine; 2016; 11():4231-46. PubMed ID: 27621618
[TBL] [Abstract][Full Text] [Related]
14. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-oleic acid-sodium alginate a hybrid nanocarrier as an efficient delivery system for enhancement of lutein stability and bioavailability.
Toragall V; Jayapala N; Vallikannan B
Int J Biol Macromol; 2020 May; 150():578-594. PubMed ID: 32057885
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies.
Mundada VP; Patel MH; Mundada PK; Sawant KK
Drug Dev Ind Pharm; 2020 Mar; 46(3):376-387. PubMed ID: 32031412
[No Abstract] [Full Text] [Related]
17. A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides.
Barbari GR; Dorkoosh FA; Amini M; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
Int J Nanomedicine; 2017; 12():3471-3483. PubMed ID: 28496323
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
[TBL] [Abstract][Full Text] [Related]
19. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
Shahbazi MA; Hamidi M; Mohammadi-Samani S
J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
[TBL] [Abstract][Full Text] [Related]
20. Curcumin nanoemulsion for transdermal application: formulation and evaluation.
Rachmawati H; Budiputra DK; Mauludin R
Drug Dev Ind Pharm; 2015 Apr; 41(4):560-6. PubMed ID: 24502271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
